Health & Diseases

Cardiac Cough in Dogs: Causes, Symptoms & Treatment

Herzhusten bezeichnet Husten, der durch eine Herzerkrankung verursacht wird — typischerweise durch ein vergrößertes Herz, das auf die Atemwege (Bronchien, Trachea) drückt, oder durch Lungenödem infolge von Herzinsuffizienz (Stauung von Flüssigkeit in der Lunge). Er ist ein Warnsymptom für fortgeschrittene Herzerkrankung.

Cardiac cough in dogs: causes, symptoms & treatment

What is cardiac cough in dogs?

Cardiac cough refers to coughing caused by heart disease — typically by an enlarged heart pressing on the airways (bronchi, trachea), or by pulmonary edema resulting from congestive heart failure (fluid congestion in the lungs). It is a warning symptom of advanced heart disease.

Important: not every cough in dogs is a cardiac cough. Differential diagnoses include bronchitis, tracheal collapse, pneumonia, and heartworms. Cardiac cough is distinguished from other causes through diagnostics (X-rays, echocardiography).

Background + scientific context

Keene et al. (2019, JVIM, PubMed 31211475) published the ACVIM consensus guidelines for myxomatous mitral valve disease (MMVD) — the most common heart disease in dogs: as it progresses, MMVD causes left atrial dilation with subsequent pressure on the left main bronchus (cough) and pulmonary edema (dyspnea, wet cough). The staging system (A–D) enables prognostic classification and treatment decisions.

Boswood et al. (2016, JVIM, PubMed 27511005) presented the EPIC study — the first large randomized controlled trial on pimobendan administration in preclinical MMVD stage B2: pimobendan prolonged the time to onset of clinical congestive heart failure by a median of 15 months. The study shows that early treatment in asymptomatic dogs with heart enlargement improves prognosis.

Häggström et al. (2008, JVIM, PubMed 18945316) investigated the comparison of pimobendan vs. benazepril in dogs with overt congestive heart failure due to MMVD in the QUEST study: pimobendan significantly prolonged survival time. Combination therapy (pimobendan + furosemide + RAAS inhibitor) is now the cardiology standard of care.

Vitomalia position

Cardiac cough is not “old-age coughing.” Dogs do not simply cough because of age. Recurrent nighttime coughing in small breeds is a warning sign that should be assessed by echocardiography — not treated with cough syrup.

When does cardiac cough in dogs become relevant?

  • In dogs >7 years, especially small breeds (Cavalier King Charles Spaniel, Chihuahua, Dachshund): MMVD predisposition
  • With dry or wet night-time coughing that has increased
  • With the combination of coughing + rapid fatigue + fainting episodes: advanced heart disease
  • With a known heart murmur at the vet: regular cardiology control
  • In dogs with positive heartworm exposure: rule out heartworm

Practical application

Distinguishing heart-related cough vs. other coughs:

Feature Heart-related cough Tracheal/infectious cough
Timing At night/early morning, after excitement Variable, after pulling on the Leash
Character Wet, productive (pulmonary edema) Dry, harsh, honking
General condition Weakness, exercise intolerance Usually unchanged
breed Small breeds, Cavalier and others All breeds
Diagnosis X-ray + echocardiography Bronchoscopy, bacterial culture

MMVD staging (simplified): - Stage A: Predisposed breed, no findings — control recommended - Stage B1: Heart murmur, no heart enlargement — observation - Stage B2: Heart murmur + heart enlargement — pimobendan indicated (according to EPIC) - Stage C: Clinical heart failure — combination therapy - Stage D: Refractory heart failure — intensified therapy

Common mistakes & myths

  • “My dog only coughs at night — that is normal." Night-time coughing is typical of heart problems — it occurs with pulmonary edema, which worsens when lying down. It is not a normal age-related issue.
  • “Treat with cough medicine until the vet appointment." Cough suppressants mask the symptom without treating the cause. If a cardiac cause is suspected, see a vet promptly.
  • “Heart-related cough is only a problem in large dogs." Small breeds are disproportionately affected by MMVD — Cavalier King Charles Spaniels develop the disease in old age in nearly 100% of cases.

Scientific status 2026

MMVD is the best-researched heart disease in dogs. Genetic tests for MMVD predisposition in Cavalier King Charles Spaniels are available. NT-proBNP as a biomarker enables non-invasive assessment of cardiac strain. Combination therapy (pimobendan + loop diuretic + ACE inhibitor + spironolactone) is the ACVIM standard for stage C/D.

Häufig gestellte Fragen

Wie klingt Herzhusten beim Hund?

Herzhusten klingt oft feucht oder produktiv — als würde der Hund etwas hochwürgen wollen, ohne dass etwas herauskommt. Er tritt häufig nachts oder nach körperlicher Anstrengung auf. Zum Vergleich: Husten bei Trachealkollaps klingt meist trocken und gackernd, Zwingerhusten eher auffällig bellend.

Was tun, wenn mein Hund nachts hustet?

Vereinbare zeitnah einen Tierarzttermin — nicht erst in einigen Wochen. In der Praxis werden meist Abhören des Herzens, Röntgenaufnahmen zur Beurteilung von Herzgröße und möglichem Lungenödem sowie bei Bedarf eine Echokardiographie eingesetzt. Bis dahin gilt: Aktivität reduzieren, Aufregung vermeiden und den Hund keinen hohen Temperaturen aussetzen.

Kann Herzhusten beim Hund behandelt werden?

Ja — Herzerkrankungen lassen sich mit Medikamenten gut kontrollieren, wenn sie früh erkannt werden. Für Pimobendan ist nachgewiesen, dass es die symptomfreie Zeit und die Überlebenszeit verlängern kann. Eine Heilung ist nicht möglich, aber Lebensqualität und Lebenserwartung können durch moderne Therapiestandards deutlich verbessert werden.

Verwandte Begriffe

Quellen & weiterführende Literatur

  1. Keene, B. W., Atkins, C. E., Bonagura, J. D., Fox, P. R., Häggström, J., Fuentes, V. L., Oyama, M. A., Rush, J. E., Stepien, R., & Uechi, M. (2019). ACVIM-Konsensusleitlinien zur Diagnose und Behandlung der myxomatösen Mitralklappenerkrankung bei Hunden. Journal of Veterinary Internal Medicine, 33(3), 1127–1140. https://pubmed.ncbi.nlm.nih.gov/31211475/

  2. Boswood, A., Häggström, J., Gordon, S. G., Wess, G., Walker, A. L., Borgarelli, M., Burkett, P., Chompoosri, S., Cunningham, S. M., et al. (2016). Wirkung von Pimobendan bei Hunden mit präklinischer myxomatöser Mitralklappenerkrankung und Kardiomegalie: Die EPIC-Studie — eine randomisierte klinische Studie. Journal of Veterinary Internal Medicine, 30(6), 1765–1779. https://pubmed.ncbi.nlm.nih.gov/27511005/

  3. Häggström, J., Boswood, A., O'Grady, M., Jöns, O., Smith, S., Swift, S., Borgarelli, M., et al. (2008). Einfluss von Pimobendan oder Benazeprilhydrochlorid auf die Überlebenszeit von Hunden mit kongestiver Herzinsuffizienz infolge einer natürlich auftretenden myxomatösen Mitralklappenerkrankung. Journal of Veterinary Internal Medicine, 22(5), 1124–1135. https://pubmed.ncbi.nlm.nih.gov/18945316/

Wissenschaftliche Einordnung

Keene et al. (2019, JVIM, PubMed 31211475) published the ACVIM consensus guidelines on myxomatous mitral valve disease (MMVD) — the most common heart disease in dogs: As MMVD progresses, it causes left atrial dilation with subsequent pressure on the left main bronchus (cough) and pulmonary edema (dyspnea, wet cough). A staging system (A–D) allows for prognostic classification and treatment decisions.

Boswood et al. (2016, JVIM, PubMed 27511005) presented the EPIC study — the first large randomized controlled trial on pimobendan administration in preclinical MMVD stage B2: Pimobendan extended the time to the onset of clinical heart failure by a median of 15 months. The study demonstrates that early therapy in asymptomatic dogs with cardiac enlargement improves prognosis.

Häggström et al. (2008, JVIM, PubMed 18945316) investigated the comparison of pimobendan vs. benazepril in dogs with overt heart failure due to MMVD in the QUEST study: Pimobendan significantly extended survival time. Combination therapy (pimobendan + furosemide + RAAS inhibitor) is now the standard cardiological treatment.